Literature DB >> 29451442

2017 McDonald MS diagnostic criteria: Evidence-based revisions.

William M Carroll1.   

Abstract

Mesh：

Year:  2018        PMID： 29451442     DOI： 10.1177/1352458517751861

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  7 in total

1.  Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS.

Authors:  Robert Zivadinov; Michael G Dwyer; Ellen Carl; Elizabeth M Poole; Steve Cavalier; Paraskevi Briassouli; Niels Bergsland
Journal:  Ther Adv Neurol Disord       Date:  2020-11-11       Impact factor: 6.570

2.  Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis.

Authors:  Roberta Amoriello; Roberta Rizzo; Alice Mariottini; Daria Bortolotti; Valentina Gentili; Elena Bonechi; Alessandra Aldinucci; Alberto Carnasciali; Benedetta Peruzzi; Anna Maria Repice; Luca Massacesi; Enrico Fainardi; Clara Ballerini
Journal:  Front Neurol       Date:  2022-05-25       Impact factor: 4.086

3.  The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies.

Authors:  Roberta Amoriello; Victor Greiff; Alessandra Aldinucci; Elena Bonechi; Alberto Carnasciali; Benedetta Peruzzi; Anna Maria Repice; Alice Mariottini; Riccardo Saccardi; Benedetta Mazzanti; Luca Massacesi; Clara Ballerini
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

4.  Optic neuritis of MOG-IgG-associated autoimmune disorders: a case report.

Authors:  Tiantian Li; Jian Zhou; Xiaoling Yan; Ran Duan; Xiaobo Zhu
Journal:  BMC Ophthalmol       Date:  2021-01-09       Impact factor: 2.209

5.  Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis.

Authors:  Fay Probert; Tianrong Yeo; Yifan Zhou; Megan Sealey; Siddharth Arora; Jacqueline Palace; Timothy D W Claridge; Rainer Hillenbrand; Johanna Oechtering; David Leppert; Jens Kuhle; Daniel C Anthony
Journal:  Brain Commun       Date:  2021-04-19

6.  Characteristics of COVID-19 in patients with multiple sclerosis.

Authors:  Fereshteh Ghadiri; Mohammad Ali Sahraian; Vahid Shaygannejad; Fereshteh Ashtari; Hamidreza Ghalyanchi Langroodi; Seyed Mohammad Baghbanian; Hossein Mozhdehipanah; Nastaran Majdi-Nasab; Samaneh Hosseini; Maryam Poursadeghfard; Nahid Beladimoghadam; Nazanin Razazian; Saeideh Ayoubi; Nasim Rezaeimanesh; Sharareh Eskandarieh; Abdorreza Naser Moghadasi
Journal:  Mult Scler Relat Disord       Date:  2021-11-30       Impact factor: 4.339

7.  TCR repertoire diversity in Multiple Sclerosis: High-dimensional bioinformatics analysis of sequences from brain, cerebrospinal fluid and peripheral blood.

Authors:  Roberta Amoriello; Maria Chernigovskaya; Victor Greiff; Alberto Carnasciali; Luca Massacesi; Alessandro Barilaro; Anna M Repice; Tiziana Biagioli; Alessandra Aldinucci; Paolo A Muraro; David A Laplaud; Andreas Lossius; Clara Ballerini
Journal:  EBioMedicine       Date:  2021-06-11       Impact factor: 8.143
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.